The Investment Column: S&N has some aces up its sleeve
Friday 27 February 1998
Earnings are likely to be flat in 1998 as the rise in sterling continues to bite, with more than 80 per cent of its earnings coming from overseas. S&N has put aside at least pounds 500m to spend on acquisitions but it has failed to find anybody to buy at a decent price.
Nor can shareholders look forward to a special dividend or share buy- back. And this perennial bid target has, conspicuously, failed to attract a takeover offer.
But S&N has several aces up its sleeve. Its big hope is Dermagraft, its revolutionary bio-engineered skin derived from the discarded foreskin of babies. S&N predicts it will bring in revenues of at least pounds 150m within three years by helping to cure foot ulcers for diabetics.
If it can be applied to other problems such as leg ulcers or cartilage injuries then it has the potential to transform S&N's finances, although this is years away.
Meanwhile S&N's profits should pick up in 1999 as the effect of sterling diminishes and the investment in Dermagraft begins to pay off. The European healthcare market remains tough, but there are signs of some improvement in the US following S&N's shake-up of its sales and marketing set up.
And, while it is sensibly cutting costs by pounds 25m or so a year it is not scrimping on its research and development budget, which can only help its long-term growth prospects.
Dresdner Kleinwort Benson forecasts current year profits of pounds 161m, putting the shares, which fell 2.5p to 173p yesterday, on a prospective p/e ratio of 17.
That looks about right for now, but if Dermagraft takes off the shares will begin to look cheap.
- 1 Howard Jacobson: Let's see the 'criticism' of Israel for what it really is
- 2 Gingers face extinction due to climate change, scientists warn
- 4 BBC’s new Game of Thrones slayer 'The Last Kingdom' relies on Saxon appeal, creators say
- 5 PornHub begs users to stop uploading video clips of Brazil getting beaten 7-1
Game of Thrones author George RR Martin says 'f*** you' to fans who fear he will die before finishing Westeros saga
Jennifer Lawrence face palms Emma Watson at Christian Dior show in Paris
Gingers face extinction due to climate change, scientists warn
Pamplona Running of the Bulls 2014: Briton critically injured in San Fermin festival
Israel's deadliest Gaza air strikes yet kill five children from same family as Palestinian rocket barrage continues
Sustained immigration has not harmed Britons' employment, say government advisers
British jihadist calls for 'flag of Islam' over Downing Street and Buckingham Palace
Australia facing international condemnation after turning around Sri Lankans at sea
7/7 memorial defaced on anniversary of 2005 attacks with ‘Blair lied thousands died’ graffiti
Even when it brutalises one of its own teenage citizens, America is helpless against Israel
There’s a nasty smell in the political air – and it’s coming from the Tories
iJobs Money & Business
£52000 - £57000 per annum + bonus, pension, private healthcare : Ashdown Group...
£60000 - £90000 per annum: Harrington Starr: A leading provider of buy side tr...
Negotiable: Harrington Starr: Electronic Platform Engineer (Linux, UNIX, Perl,...
£25000 - £30000 per annum: Harrington Starr: Market Making Support Analyst - (...